Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts
Authors
Keywords
Prostate cancer, Phosphorylation, Cancer treatment, Prostate gland, Lymph nodes, Lung and intrathoracic tumors, Secondary lung tumors, Embryos
Journal
PLoS One
Volume 10, Issue 6, Pages e0130340
Publisher
Public Library of Science (PLoS)
Online
2015-06-16
DOI
10.1371/journal.pone.0130340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pim-1 Kinase Expression Predicts Radiation Response in Squamocellular Carcinoma of Head and Neck and Is under the Control of Epidermal Growth Factor Receptor
- (2015) Katriina Peltola et al. NEOPLASIA
- PIM Kinases Are Essential for Chronic Lymphocytic Leukemia Cell Survival (PIM2/3) and CXCR4-Mediated Microenvironmental Interactions (PIM1)
- (2014) S. Decker et al. MOLECULAR CANCER THERAPEUTICS
- A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas
- (2014) Jason M. Foulks et al. NEOPLASIA
- Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update
- (2013) Gubbi M Arunesh et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Tricyclic Benzo[cd]azulenes Selectively Inhibit Activities of Pim Kinases and Restrict Growth of Epstein-Barr Virus-Transformed Cells
- (2013) Alexandros Kiriazis et al. PLoS One
- PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
- (2012) L Brault et al. BRITISH JOURNAL OF CANCER
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors
- (2010) F. Anizon et al. CURRENT MEDICINAL CHEMISTRY
- Pim kinase inhibitors: a survey of the patent literature
- (2010) Tina Morwick EXPERT OPINION ON THERAPEUTIC PATENTS
- PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
- (2010) L. Brault et al. HAEMATOLOGICA
- Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 Signaling
- (2010) John M. Busillo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma
- (2010) Hong-Tao Liu et al. JOURNAL OF SURGICAL ONCOLOGY
- Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
- (2010) Niina M Santio et al. Molecular Cancer
- CXCR4 and cancer
- (2010) Bungo Furusato et al. PATHOLOGY INTERNATIONAL
- Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors
- (2009) Johanna Tuomela et al. BMC CANCER
- Pim-3 is expressed in endothelial cells and promotes vascular tube formation
- (2009) Peng Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration
- (2009) Rebekka Grundler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Synthesis, Kinase Inhibitory Potencies, and in Vitro Antiproliferative Evaluation of New Pim Kinase Inhibitors
- (2009) Rufine Akué-Gédu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzo[cd]azulene Skeleton: Azulene, Heptafulvene, and Tropone Derivatives
- (2009) Ingo B. Aumüller et al. ORGANIC LETTERS
- Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice
- (2008) Johanna M Tuomela et al. BMC CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now